[Melatoninergic antidepressant valdoxan]
- PMID: 21894769
[Melatoninergic antidepressant valdoxan]
Abstract
Data on the pharmacological properties, mechanism of action, and clinical advantages of the new antidepressant drug valdoxan capable of selectively stimulating melatonin receptors are presented. The drug effect is compared to the action of epiphyseal hormone melatonin and traditional antidepressants.
Similar articles
-
Mechanism of action of agomelatine: a novel antidepressant exploiting synergy between monoaminergic and melatonergic properties.CNS Spectr. 2014 Jun;19(3):207-12. doi: 10.1017/S1092852914000248. CNS Spectr. 2014. PMID: 24901504
-
Melatonin and melatonergic drugs on sleep: possible mechanisms of action.Int J Neurosci. 2009;119(6):821-46. doi: 10.1080/00207450802328607. Int J Neurosci. 2009. PMID: 19326288 Review.
-
Therapeutic potential of agomelatine in epilepsy and epileptic complications.Med Hypotheses. 2014 Jan;82(1):105-10. doi: 10.1016/j.mehy.2013.11.017. Epub 2013 Nov 21. Med Hypotheses. 2014. PMID: 24314750
-
[Lights off? Neurobiological and pharmacological aspects of the melatonergic-serotonergic synergism].Neuropsychopharmacol Hung. 2010 Dec;12(4):469-75. Neuropsychopharmacol Hung. 2010. PMID: 21220792 Review. Hungarian.
-
[Modern approaches to the synchronization of circadian rhythms in treatment of depression].Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(11):124-8. Zh Nevrol Psikhiatr Im S S Korsakova. 2014. PMID: 25629135 Review. Russian.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical